ERG Rearrangement Status in Prostate Cancer Detected by Immunohistochemistry

被引：0
|
作者：
Falzarano, S. M. [1 ]
Zhou, M. [1 ]
Carver, P. [1 ]
He, H. [1 ]
Magi-Galluzzi, C. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
804
引用
收藏
页码：191A / 191A
页数：1
相关论文
共 50 条
  • [41] TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry
    Gopalan, Anuradha
    Leversha, Margaret A.
    Dudas, Maria E.
    Maschino, Alexandra C.
    Chang, Jeremy
    Al-Ahmadie, Hikmat A.
    Chen, Ying-Bei
    Tickoo, Satish K.
    Reuter, Victor E.
    Fine, Samson W.
    HISTOPATHOLOGY, 2013, 63 (02) : 279 - 286
  • [42] Single Focus Prostate Cancer: Pathological Features and ERG Fusion Status
    Falzarano, Sara M.
    Zhou, Ming
    Hernandez, Adrian V.
    Klein, Eric A.
    Rubin, Mark A.
    Magi-Galluzzi, Cristina
    JOURNAL OF UROLOGY, 2011, 185 (02): : 489 - 494
  • [43] ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS WITH ERG FUSION STATUS IN PROSTATE CANCER
    Kohaar, Indu
    Chen, Yongmei
    Ravindranath, Lakshmi
    Young, Denise
    Ali, Amina
    Li, Qiyuan
    McLeod, David
    Rosner, Inger
    Sesterhenn, Isabell
    Spring, Silver
    Cullen, Jennifer
    Freedman, Matthew
    Srivastava, Shiv
    Petrovics, Gyorgy
    JOURNAL OF UROLOGY, 2018, 199 (04): : E938 - E938
  • [44] Cohort Design and Localization Is Critical for the Understanding of the Clinical Implications of Prostate Cancer with ERG Rearrangement
    Braun, M.
    Scheble, V. J.
    Wilbertz, T.
    Stiedl, A. C.
    Petersen, K.
    Schilling, D.
    Kuefer, R.
    Fend, F.
    Kristiansen, G.
    Rubin, M. A.
    Perner, S.
    MODERN PATHOLOGY, 2010, 23 : 181A - 181A
  • [45] TMPRSS2:: Erg rearrangement is an independent marker of good prognosis in prostate cancer
    Saramaki, Outi
    Harjula, Anna
    Martikainen, Paula
    Vessella, Robert
    Tammela, Teuvo
    Visakorpi, Tapio
    CELLULAR ONCOLOGY, 2008, 30 (02) : 120 - 120
  • [46] Rearrangement of ERG and CHD1 genes in prostate cancer as a marker of tumor heterogeneity
    Tereshchenko, Irina V.
    Zhong, Hua
    Chekmareva, Marina
    Santanam, Urmila
    Petrosky, Whitney
    Kane-Goldsmith, Noriko
    Tischfield, Jay A.
    DiPaola, Robert
    CANCER RESEARCH, 2014, 74 (19)
  • [47] Cohort Design and Localization Is Critical for the Understanding of the Clinical Implications of Prostate Cancer with ERG Rearrangement
    Braun, M.
    Scheble, V. J.
    Wilbertz, T.
    Stiedl, A. C.
    Petersen, K.
    Schilling, D.
    Kuefer, R.
    Fend, F.
    Kristiansen, G.
    Rubin, M. A.
    Perner, S.
    LABORATORY INVESTIGATION, 2010, 90 : 181A - 181A
  • [48] The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
    Pettersson, Andreas
    Graff, Rebecca E.
    Bauer, Scott R.
    Pitt, Michael J.
    Lis, Rosina T.
    Stack, Edward C.
    Martin, Neil E.
    Kunz, Lauren
    Penney, Kathryn L.
    Ligon, Azra H.
    Suppan, Catherine
    Flavin, Richard
    Sesso, Howard D.
    Rider, Jennifer R.
    Sweeney, Christopher
    Stampfer, Meir J.
    Fiorentino, Michelangelo
    Kantoff, Philip W.
    Sanda, Martin G.
    Giovannucci, Edward L.
    Ding, Eric L.
    Loda, Massimo
    Mucci, Lorelei A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (09) : 1497 - 1509
  • [49] TMPRSS2: ERG rearrangement is an independent marker of good prognosis in prostate cancer
    Saramaeki, O. R.
    Harjula, A. E.
    Martkainen, P. M.
    Vessella, R. L.
    Tammela, T. L. J.
    Visalkorpi, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 253 - 253
  • [50] ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
    Scheble, Veit J.
    Braun, Martin
    Beroukhim, Rameen
    Mermel, Craig H.
    Ruiz, Christian
    Wilbertz, Theresia
    Stiedl, Ann-Cathrin
    Petersen, Karen
    Reischl, Markus
    Kuefer, Rainer
    Schilling, David
    Fend, Falko
    Kristiansen, Glen
    Meyerson, Matthew
    Rubin, Mark A.
    Bubendorf, Lukas
    Perner, Sven
    MODERN PATHOLOGY, 2010, 23 (08) : 1061 - 1067
12345